Traumatic brain injuries are among the most difficult injuries to heal. In addition to causing problems such as slurred speech and logic problems, studies have shown that people who suffer long-lasting symptoms from their injuries are more likely to develop mental health issues, including speech disorder. post-traumatic stress (PTSD), depression and suicidal tendencies. thoughts.

Up to 30% of those who survive brain damage develop…

Learn more>>

NOTICE TO INVESTORS: The latest news and updates regarding Odyssey Health Inc. (OTC: ODYY) can be found in the company’s newsroom at https://ibn.fm/ODYY

About BioMedWire

BioMedWire (BMW) is a biomedical news and content distribution company that provides (1) access to a network of wireline services through InvestorWire to reach all target markets, industries and demographics in the most efficient way possible , (2) articles and editorials syndication to over 5,000 news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via Investor Brand Network (IBN) to nearly 2 million followers, (5) a full suite of business communications solutions, and (6) a comprehensive news coverage solution with BMW Prime. As a multi-faceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to better serve private and public companies seeking to reach a wide audience of investors, consumers, journalists and the general public. By reducing the information overload in today’s market, BMW provides customers with unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS alerts from BioMedWire, text “Biotech” to 844-397-5787 (US cell phones only)

For more information, please visit https://www.BioMedWire.com

Please review the full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or republished: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.